Factors Associated with Medication Adherence among Glaucoma Patients in Ibadan, Oyo State, Nigeria
DOI:
https://doi.org/10.47941/ijhmnp.3539Keywords:
Glaucoma, Medication adherence, Adherence factors, BlindnessAbstract
Purpose: Managing glaucoma, the leading cause of irreversible blindness, entails the daily use of eye drops; and non-adherence to medication regimens is a problem in glaucoma management. This study assessed the predictors associated with medication adherence for glaucoma patients.
Methodology: A cross-sectional survey design was used. The study was conducted in 15 selected eye hospitals in Ibadan, Oyo State, Nigeria. A total of 126 glaucoma-consenting patients were interviewed using a questionnaire. Knowledge of glaucoma severity, medication adherence, and factors associated with medication adherence were measured. Data were analysed; descriptive and inferential statistics were done with the level of significance set at ≤ 0.05.
Findings: Most (95.2%) respondents had fair or good knowledge of glaucoma severity. However, only 32.5% of them adhered to their daily medication use. Knowledge was associated with education, occupation, and age, while medication adherence was associated with age and diagnosed period. The driving factors were the availability of social support, healthcare accessibility, communication, and patient education; medication reminders and follow-ups; glaucoma support groups; fear of blindness; and knowledge of glaucoma severity. The restraining factors were the cost of medication, life stress, glaucoma eyedrop side effects, multiple drug dosing, and efficacy in eyedrop self-administration.
Unique contribution to theory, practice and policy: Notwithstanding knowledge, restraining factors are more influential than driving factors in predicting adherence to medication for glaucoma patients. Clinicians should always identify and pay attention to these factors associated with medication adherence (especially the restraining factors) when managing glaucoma patients in order to avoid blindness despite being on treatment.
Downloads
References
1. World Glaucoma Association. World Glaucoma Association What is glaucoma? Published 2022. Accessed October 27, 2022. https://wga.one/wga/what-is-glaucoma/
2. Cohen LP, Pasquale LR. Clinical characteristics and current treatment of glaucoma. Cold Spring Harb Perspect Med. 2014;4(6). doi:10.1101/cshperspect.a017236
3. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: A review. JAMA. 2014;311(18). doi:10.1001/jama.2014.3192
4. Abdull MM, Chandler C, Gilbert C. Glaucoma, “the silent thief of sight”: Patients’ perspectives and health seeking behaviour in Bauchi, northern Nigeria. BMC Ophthalmol. 2016;16(1). doi:10.1186/s12886-016-0220-6
5. Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267. doi:10.1136/BJO.2005.081224
6. Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus. Published online 2020. doi:10.7759/cureus.11686. Accessed October 27, 2022.
7. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology. 2014;121(11). doi:10.1016/j.ophtha.2014.05.013
8. Kyari F, Entekume G, Rabiu M, et al. A Population-based survey of the prevalence and types of glaucoma in Nigeria: Results from the Nigeria National Blindness and Visual Impairment Survey. BMC Ophthalmol. 2015;15(1). doi:10.1186/s12886-015-0160-6
9. Ashaye A, Ashaolu O, Komolafe O, et al. Prevalence and types of glaucoma among an indigenous African population in southwestern Nigeria. Invest Ophthalmol Vis Sci. 2013;54(12). doi:10.1167/iovs.13-12698
10. WHO. Adherence to Long-term therapies. Evidence for action. World Health Organisation ISBN 92 4 154599 2. Published online 2003. Accessed October 27, 2022.
11. Mansberger SL, Sheppler CR, McClure TM, et al. Psychometrics of A New Questionnaire to Assess Glaucoma Adherence: The Glaucoma Treatment Compliance Assessment Tool (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2013;111:1. Accessed December 30, 2022. /pmc/articles/PMC3783251/
12. Zaharia AC, Dumitrescu OM, Radu M, Rogoz RE. Adherence to Therapy in Glaucoma Treatment—A Review. J Pers Med. 2022;12(4). doi:10.3390/JPM12040514
13. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015. doi:10.1155/2015/217047
14. Omolase CO, Ogunleye OT, Sotiloye OA, Akinwalere AK, Adeosun OA, Omolase BO. Compliance with topical glaucoma medications in Owo, Nigeria. Brunei International Medical Journal. 2013;9(3).
15. Onakoya A, Mbadugha C. Self-reported adherence rates in glaucoma patients in Southwest Nigeria. Journal of Clinical Sciences. 2016;13(2). doi:10.4103/2408-7408.179649
16. Assem AS, Fekadu SA, Yigzaw AA, Nigussie ZM, Achamyeleh AA. Level of Glaucoma Drug Adherence and Its Associated Factors Among Adult Glaucoma Patients Attending Felege Hiwot Specialized Hospital, Bahir Dar City, Northwest Ethiopia. Clin Optom. 2020;12:189-197. doi:10.2147/OPTO.S274850
17. Robin AL, Muir KW. Medication adherence in patients with ocular hypertension or glaucoma. Expert Rev Ophthalmol. 2019;14:199-210.doi:10.1080/17469899.2019.1635456
18. Osahon PT, Mote LA, Ntaji VI. Assessment of the impact of medPlan®, a medication reminder mobile application, in glaucoma patients in Benin City, Nigeria. Tropical Journal of Pharmaceutical Research. 2020;19(12). doi:10.4314/tjpr.v19i12.28
19. Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: A systematic scoping review. Heliyon. 2022;8(6):e09716. doi:10.1016/J.HELIYON.2022.E09716
20. Dreer LE, Owsley C, Campbell L, Gao L, Wood A, Girkin CA. Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence among African Americans: “G laucoma Management Optimism for African Americans Living with Glaucoma” (GOAL). Curr Eye Res. 2016;41(1). doi:10.3109/02713683.2014.1002045
21. Newman-Casey PA, Robin AL, Blachley T, et al. Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey HHS Public Access. Ophthalmology. 2014;122(7):1308-1316. doi: 10.1016/j.ophtha.2015.03.026
22. AMA Ed Hub. Medication Adherence: Improve Patient Outcomes and Reduce Costs | Health Care Quality | AMA STEPS Forward | AMA Ed Hub. Published 2015. Accessed November 2, 2022. https://edhub.ama-assn.org/steps-forward/module/2702595
23. Tshivhase SE, Khoza LB, Tshitangano TG. Application of the Information-Motivation-Behavioural Skills Model to Strengthen Eye Care Follow-Up Amongst Glaucoma Patients. African Vision and Eye Health. 2021;80(1):1-8. doi:10.4102/AVEH.V80I1.642
24. Kizor-Akaraiwe NN, Monye HI, Okeke S. Awareness and knowledge about glaucoma and proportion of people with glaucoma in an urban outreach programme in Southeast Nigeria. BMJ Open Ophthalmol. 2017;1(1). doi:10.1136/BMJOPHTH-2016-000018
25. Abraham EG, Megbelayin EO, Uwah AI. (PDF) Awareness and Knowledge of Glaucoma among General Medical Outpatients in a Nigerian Tertiary Hospital, Uyo Experience. W J Biomed Res. Published 2018. Accessed April 29, 2023.
26. Abu Hassan DW, Alsibai BA, Alhouri AN, Alhajeh RY, Suleiman AA, Al Bdour MD. Awareness and knowledge about glaucoma among patients attending outpatient clinics of Jordan University Hospital. Saudi journal of ophthalmology: official journal of the Saudi Ophthalmological Society. 2021;34(4), 284–289. https://doi.org/10.4103/1319-4534.322618
27. Nkum G, Lartey S, Frimpong C, Micah F, Nkum B. Awareness and Knowledge of Glaucoma Among Adult Patients at the Eye Clinic of a Teaching Hospital. Ghana Medical Journal. 2015;49(3), 195–199. https://doi.org/10.4314/gmj.v49i3.11
28. Guven S, Koylu MT, Mumcuoglu T. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population. Eur J Ophthalmol. 2021;31(2):469-476. doi:10.1177/1120672120901687
29. Kim CY, Park KH, Ahn J, et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. British Journal of Ophthalmology. 2017;101(6):801-807. doi:10.1136/BJOPHTHALMOL-2016-308505
30. Kayode OA, Christianah OF, Iyiade IA, Olusola JO. Reported medication adherence by glaucoma patients in a Nigeria hospital. Adv Ophthalmol Vis Syst. 2019; 9(5):129-121. doi:10.15406/AOVS.2019.09.00363
31. Dwajani S., Prabhu MR, Ranjana G., Sahajananda H. Importance of medication adherence and factors affecting it. IP International Journal of Comprehensive and Advanced Pharmacology; 3(2). Published 2018. Accessed December 26, 2022.
32. Ramesh P, Parthasarathi S, John R. An exploratory study of compliance to anti-glaucoma medications among literate primary glaucoma patients at an urban tertiary eye care center in South India. Indian J Ophthalmol. 2021;69(6). doi: 10.4103/ijo.IJO_2008_20
33. Hwang IC, Suh HS, Choi S. Factors Associated with Non-Adherence to Glaucoma Treatment in a Korean Nationwide Survey. Iran J Public Health. 2022 Jun;51(6):1259-1264. doi: 10.18502/ijph.v51i6.9669. PMID: 36447979; PMCID: PMC9659527.
34. Aina A, Olawoye O, Oluleye T. Factors affecting compliance with glaucoma medications in Nigeria. South African Ophthalmology Journal. 2018 Mar 1;13(1):17-21.
35. Tsai JC. Medication adherence in glaucoma: Approaches for optimising patient compliance. Curr Opin Ophthalmol. 2006;17(2).doi: 10.1097/01.icu.0000193078.47616.aa
36. Ogunleye O, Olawoye O, Sarimiye T, Bekibele C, Ashaye A. The Effect of Direct Health Education on the Uptake of Screening by First Degree Relatives of Glaucoma Patients in Nigeria. J Glaucoma. 2021;30(5). doi:10.1097/IJG.0000000000001769
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Patrick Chukwuemeka Okafor, Adaeze Chiamaka Ezeh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
